Spun out of the University of Oxford in 2014, Genomics plc now employs over 100 people in the UK and the US, and leads the world in understanding the genetic components of common diseases and disease risk. It embeds the power of genomics in its products and solutions, which can transform every aspect of healthcare, from drug discovery to clinical trial design, from disease prevention to screening and early diagnosis, and from treatment selection for fully personalised care to population health.
King Charles House, Park End St, Oxford OX1 1JD